NCT06088290 2026-04-17
SaLuDo
PharmaMar
Phase 3 Recruiting
Clinical Trials
4 trialsNCT04031677 2026-03-31
STRASS2
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Recruiting
NCT03016819 2026-02-25
APROMISS
Advenchen Laboratories, LLC
Phase 3 Recruiting
NCT05712694 2025-07-17
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Polaris Group
Phase 3 Recruiting